Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001746473-22-000021
Filing Date
2022-05-09
Accepted
2022-05-09 16:18:41
Documents
83
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q plrx-20220331.htm   iXBRL 10-Q 1385748
2 EX-31.1 plrx-20220331xex311.htm EX-31.1 10526
3 EX-31.2 plrx-20220331xex312.htm EX-31.2 10494
4 EX-32.1 plrx-20220331xex321.htm EX-32.1 7368
  Complete submission text file 0001746473-22-000021.txt   6031943

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT plrx-20220331.xsd EX-101.SCH 54415
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT plrx-20220331_cal.xml EX-101.CAL 46432
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT plrx-20220331_def.xml EX-101.DEF 252705
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT plrx-20220331_lab.xml EX-101.LAB 572443
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT plrx-20220331_pre.xml EX-101.PRE 390775
77 EXTRACTED XBRL INSTANCE DOCUMENT plrx-20220331_htm.xml XML 764157
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

EIN.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39303 | Film No.: 22905245
SIC: 2834 Pharmaceutical Preparations